Abstract
Subclinical hypothyroidism is a condition characterized by increased levels of thyroid-stimulating hormone (TSH) associated with normal levels of free triiodothyronine (FT3) and free thyroxine (FT4). The exact prevalence of this condition in Italy is not known. The aim of this study was to assess the presence of subclinical hypothyroidism in 1001 subjects living in the Milan area (age 17–89) and apparently free from thyroid pathology. This sample which had applied to a large laboratory centre (Centro Diagnostico Italiano, Milano) for a routine check-up was seen from April to July 1996. A serum TSH assay was performed using a highly sensitive immunoenzymatic method, while an FT3 and FT4 assay was performed by means of a radioimmunologic method using commercial kits. The prevalence of subclinical hypothyroidism in the total population proved to be 4.7% (95% CI-Confidence Interval: 3.4–6.0). Sex stratification showed a prevalence of 6.1% in females and 3.4% in males. Prevalence in patients up to 65 was 4.2%. This value increased up to 8.0% in subjects over 65. By combining these variables, in females >65 prevalence increased to 11.3%. Overall, symptoms typical of overt hypothyroidism were found in 58.3% of patients suffering from subclinical hypothyroidism and in 39.9% of healthy subjects (p<0.02). The results of this study show that there is a significant presence (about 5%) of subclinical hypothyroidism in this population and that its frequency is more than doubled in women over 65. Early treatment might reduce the progression to overt hypothyroidism. The benefits of such a procedure were recently suggested by a decision making modelling approach applied to the Italian environment.
Similar content being viewed by others
References
Brown C.A., Hennessey J.V. Clinical significance of mildly elevated thyrotropin levels with normal thyroxine levels. South Med. J. 1989, 82: 681–685.
Tunbridge W.M.G., Evered D.C., Hall R., Appleton D., Brewis M., Clark F., Evans J.G., Young E., Bird T., Smith P.A. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf) 1977, 7: 481–493.
Bemben D.A., Hamm R.M., Morgan L., Winn P., Davis A., Barton E. Thyroid disease in the elderly. Part 2. Predictability of subclinical hypothyroidism. J. Fam. Pract. 1994, 38: 583–588.
Rosenthal M.J., Hunt W.C., Garry P.J., Goodwin J.S. Thyroid failure in the elderly. Microsomal antibodies as discriminant for therapy. JAMA 1987, 258: 209–213.
Manciet G., Dartigues J.F., Decamps A., Barberger-Gateau P., Letenneur L., Latapie M.J., Latapie J.L. The PAQUID survey and correlates of subclinical hy- pothyroidism in elderly community residents in the southwest of France. Age Ageing 1995, 24: 235–241.
Schaaf L., Pohl T., Schmidt R., Vardali I., Teuber J., Schlote-Sauter B., Nowotny B., Schiebeler H., Zober A., Usadel K.H. Screening for thyroid disorders in a working population. Clin. Investig. 1993, 71: 126–131.
Hintze G., Burghardt U., Baumert J., Windeler J., Kobberling J. Prevalence of thyroid dysfunction in elderly subjects from the general population in an iodine deficiency area. Aging (Milano) 1991, 3: 325–331.
Brochmann H., Bjoro T., Gaarder P.I., Hanson F., Frey H.M. Prevalence of thyroid disorders in elderly subjects. A randomized study in a Norvegian rural community (Naeroy). Acta Endocrinol (Copenh.) 1988, 117: 7–12.
Okamura K., Nakashima T., Ueda K., Inoue K., Omae T., Fujishima M. Thyroid disorders in the general population of Hisayama Japan, with special reference to preva-lence and sex differences. Int. J. Epidemiol. 1987, 16: 545–549.
Muller G.M., Levitt N.S., Louw S.J. Thyroid disfunction in the elderly. S. Afr. Med. J. 1997, 87: 1119–1123.
Jaeschke R., Guyatt G., Gerstein H., Patterson C., Molloy W., Cook D., Harper S., Griffith L., Carbotte K. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J. Gen. Intern. Med. 1996, 11: 744–749.
Cooper D.S., Halpern R., Wood L.C., Levin A.A., Ridgway E.C. L-thyroxine therapy in subclinical hypothyroidism. Ann. Intern. Med. 1984, 101: 18–24.
Staub J.J., Althaus B.U., Engler H., Ryff A.S., Trabucco P., Marquardt K., Burckhardt D., Girard J., Weintraub B.D. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am. J. Med. 1992, 92: 631–642.
Miura S., Iitaka M., Yoshimura H., Kitahama S., Fukasawa N., Kawakami Y., Sakurai S., Urabe M., Sakatsume Y., Ito K. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy. Int. Med. 1994, 33: 413–417.
Tunbridge W.M., Brewis M., French J.M., Appleton D., Bird T., Clark F., Evered D.C., Grimley Evans J., Hall K., Smith P., Stephenson J., Young E. Natural history of autoimmune thyroiditis. Br. Med. J. 1981, 282: 258–262.
Adlin V. Subclinical hypothyroidism: deciding when to treat. Am. Fam. Physician 1998, 57: 776–780.
Cushing G.W. Subclinical hypothyroidism. Understanding is the key to decision making. Postgrad. Med. 1993, 94: 95–97.
Monzani F., Caraccio N., Siciliano G., Manca L., Murri L., Ferrannini E. Clinical and biochemical features of muscle dys-function in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 1997, 82: 3315–3318.
Wiersinga W.M. Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance. Neth. J. Med. 1995, 46: 197–204.
Miller M.J., Pan C., Barzel U.S. The prevalence of subclinical hypothyroidism in adults with low-normal blood thyroxine levels. N. Y. State J. Med. 1990, 90: 541–544.
Woeber K.A. Subclinical thyroid disfunction. Arch. Intern. Med. 1997, 57: 1065–1068.
U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2nd ed. Baltimore, Williams & Wilkins, 1996.
Helfand M., Crapo L.M. Screening for thyroid disease. Ann. Intern. Med. 1990, 112: 840–849.
Danese M.D., Powe N.R., Sawin C.T., Landenson P.W. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996, 276: 285–292.
Bona M., Santini F., Rivolta G., Grossi E., Grilli R. Cost effectiveness of screening for subclinical hypothy- roidism in the elderly. A decision-analytical model. Pharmacoeconomics 1998, 14: 209–216.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rivolta, G., Cerutti, R., Colombo, R. et al. Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area. J Endocrinol Invest 22, 693–697 (1999). https://doi.org/10.1007/BF03343631
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343631